The clinical value of whole body Fluorine-18 Fluorodeoxyglucose PET/CT for detecting metastatic bladder cancer

被引：0
|
作者：
Yang, Zhongyi [1 ]
Zhang, Yingjian [1 ]
机构：
[1] Shanghai Canc Ctr, Nucl Med, Shanghai, Peoples R China
来源：
JOURNAL OF NUCLEAR MEDICINE | 2012年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
1408
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Clinical value of whole body fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in the detection of metastatic bladder cancer
    Yang, Zhongyi
    Pan, Lingling
    Cheng, Jingyi
    Hu, Silong
    Xu, Junyan
    Ye, Dingwei
    Zhang, Yingjian
    [J]. INTERNATIONAL JOURNAL OF UROLOGY, 2012, 19 (07) : 639 - 644
  • [2] Clinical value of fluorine-18α-methyltyrosine PET in patients with gliomas: comparison with fluorine-18 fluorodeoxyglucose PET
    Keishi Horiguchi
    Masahiko Tosaka
    Tetsuya Higuchi
    Yukiko Arisaka
    Kenichi Sugawara
    Junko Hirato
    Hideaki Yokoo
    Yoshito Tsushima
    Yuhei Yoshimoto
    [J]. EJNMMI Research, 7
  • [3] Is whole body Fluorine-18 Fluorodeoxyglucose PET/CT plus additional pelvic images (oral hydration-voiding-refilling) useful for detecting recurrent bladder cancer?
    Yang, Zhongyi
    Zhang, Yingjian
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [4] Is whole-body fluorine-18 fluorodeoxyglucose PET/CT plus additional pelvic images (oral hydration–voiding–refilling) useful for detecting recurrent bladder cancer?
    Zhongyi Yang
    Jingyi Cheng
    Lingling Pan
    Silong Hu
    Junyan Xu
    Yongping Zhang
    Mingwei Wang
    Jianping Zhang
    Dingwei Ye
    Yingjian Zhang
    [J]. Annals of Nuclear Medicine, 2012, 26 : 571 - 577
  • [5] Is whole-body fluorine-18 fluorodeoxyglucose PET/CT plus additional pelvic images (oral hydration-voiding-refilling) useful for detecting recurrent bladder cancer?
    Yang, Zhongyi
    Cheng, Jingyi
    Pan, Lingling
    Hu, Silong
    Xu, Junyan
    Zhang, Yongping
    Wang, Mingwei
    Zhang, Jianping
    Ye, Dingwei
    Zhang, Yingjian
    [J]. ANNALS OF NUCLEAR MEDICINE, 2012, 26 (07) : 571 - 577
  • [6] The value of fluorine-18 fluorodeoxyglucose PET in patients with medullary thyroid cancer
    Brandt-Mainz, K
    Müller, SP
    Görges, R
    Saller, B
    Bockisch, A
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2000, 27 (05) : 490 - 496
  • [7] Clinical value of fluorine-18a-methyltyrosine PET in patients with gliomas: comparison with fluorine-18 fluorodeoxyglucose PET
    Horiguchi, Keishi
    Tosaka, Masahiko
    Higuchi, Tetsuya
    Arisaka, Yukiko
    Sugawara, Kenichi
    Hirato, Junko
    Yokoo, Hideaki
    Tsushima, Yoshito
    Yoshimoto, Yuhei
    [J]. EJNMMI RESEARCH, 2017, 7
  • [8] How do oncologists deal with incidental abnormalities on whole-body fluorine-18 fluorodeoxyglucose PET/CT?
    Wang, Guohui
    Lau, Eddie W. F.
    Shakher, Ramdave
    Rischin, Danny
    Ware, Robert E.
    Hong, Emily
    Birms, David S.
    Hogg, Annette
    Drummond, Elizabeth
    Hicks, Rodney J.
    [J]. CANCER, 2007, 109 (01) : 117 - 124
  • [9] Fluorine-18 fluorodeoxyglucose PET in the management of breast cancer
    Corone, C
    Collignon, MA
    Alberini, JL
    Pichon, MF
    Pecking, AP
    [J]. EUROCANCER 2002, 2002, : 23 - 24
  • [10] Staging of primary colorectal carcinomas with fluorine-18 fluorodeoxyglucose whole-body PET: Correlation with histopathologic and CT findings
    Abdel-Nabi, H
    Doerr, RJ
    Lamonica, DM
    Cronin, VR
    Galantowicz, P
    Carbone, GM
    Spaulding, MB
    [J]. RADIOLOGY, 1998, 206 (03) : 755 - 760
12345